Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...
These may not only appeal to more people, avoiding the need for weekly injections, but are also likely to benefit patients who have a wide range of medical conditions ... doctors have said. The new ...
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.